Drawing for CNS HEALTHCARE

USPTO serial 76447800

CNS HEALTHCARE

Reviewed by CopyMark Law Group

Reg. 2912025Status 710
Filing date
Status date
Registration date
Dec 21, 2004
Examiner
MANDIR, FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CNS HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael D. West

HUEY, GUILDAY, TUCKER, SCHWARTZMICHAEL D W1983 CTR POINTE BLVD STE 200TALLAHASSEE, FL 32308

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical drug development services, featuring, conducting, managing, and administering clinical trial studies of pharmaceuticals, recruiting clinical trial subjects and adverting clinical trial requirements in multiple media, including the internet, all done as components of pharmaceutical drug development servicesSECTION 8 - CANCELLEDAug 30, 2001

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2011C8..CANCELLED SEC. 8 (6-YR)—
Dec 21, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 28, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 8, 2004NPUBNOTICE OF PUBLICATION—
Jul 30, 2004ALIEASSIGNED TO LIE—
Jul 15, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2004MAILPAPER RECEIVED—
Dec 19, 2003GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 25, 2003CFITCASE FILE IN TICRS—
Nov 14, 2003REINREINSTATED—
Aug 12, 2003PETRPETITION TO REVIVE-RECEIVED—
Aug 8, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 28, 2003MAILPAPER RECEIVED—
Jul 25, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2003MAILPAPER RECEIVED—
Dec 10, 2002GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance